2018 ASCO-SITC Clinical Immuno-Oncology Symposium Public

Katelyn T. Byrne, PhD, speaks during General Session 7: Emerging Targets in Immunotherapy

San Francisco, CA - 2018 Clinical Immuno-Oncology Symposium – Katelyn T. Byrne, PhD, speaks during General Session 7: Emerging Targets in Immunotherapy at the 2018 ASCO-SITC Clinical Immuno-Oncology Symposium here today, Saturday, Jan. 27, 2018. The conference, which is a collaboration between the American Society of Clinical Oncology and Society for Immunotherapy of Cancer, is focused on clinical and translational research in immuno-oncology and the implications for clinical care. Photo by © ASCO/Scott Morgan 2018.